Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

314.20
+2.230.71%
Post-market: 314.200.00000.00%17:47 EDT
Volume:703.73K
Turnover:220.67M
Market Cap:25.42B
PE:26.02
High:315.48
Open:312.34
Low:309.04
Close:311.97
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:1.04
T/O Rate:0.87%
Dividend:2.88
Dividend Rate:0.92%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:2.95
PE(LYR):30.04

Loading ...

Does Labcorp’s New RNA At‑Home ColoSense Screening Win Shift The Bull Case For LH?

Simply Wall St.
·
Jun 24

Labcorp Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 24

Labcorp Says ColoSense Colorectal Cancer Screening Test Available Nationwide

MT Newswires Live
·
Jun 22

Labcorp Announces Nationwide Availability of Colosense®, the First FDA-Approved Rna-Based at-Home Colorectal Cancer Screening Test

THOMSON REUTERS
·
Jun 22

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 19

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

GeneDx names former Quest executive Mark Gardner as president

Reuters
·
Jun 16

Labcorp announces Q2 2026 dividend of R$ 0.62 per unit

Reuters
·
Jun 16

Labcorp sets BRL 0.62 per BDR dividend, payable June 17

Reuters
·
Jun 13

Labcorp Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

Does Labcorp’s New Oncology Genetics Initiatives Shift the Precision Medicine Narrative For Labcorp (LH)?

Simply Wall St.
·
Jun 11

LH Group Wins Full Shareholder Backing for AGM Resolutions and Capital Mandates

TIPRANKS
·
Jun 10

Labcorp EVP, Chief Legal Officer Kathryn W. Kyle sells 762 common shares for $201,084.18

Reuters
·
Jun 10

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 10

Labcorp Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09

Genfit, Labcorp expand access to NASHnext liver risk test via Labcorp OnDemand platform

Reuters
·
Jun 09

Genfit: Nashnext®, Powered by Genfit's Non-Invasive Diagnostic Technology Nis4®, Launched via Labcorp’s Ondemand Offering for Identification of at-Risk Mash

THOMSON REUTERS
·
Jun 09

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 06

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Moderna (MRNA) and Celcuity (CELC)

TIPRANKS
·
Jun 02

Labcorp Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02